V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20213646 | 20129420 | 1.62 | 55.4 | Neo-adjuvant (N) | 2019-05-01 | 2019-05-20 | Oxaliplatin + Raltitrexed | 01 | Y | OXALIPLATIN + RALTITREXED | 101194452 |
| 20213647 | 20129421 | 1.55 | 117 | Not known (9) | 2018-06-16 | 2018-08-25 | EOX | 02 | null | SORAFENIB | 100461052 |
| 20213648 | 20129422 | 1.58 | 107.5 | Disease modification (D) | 2016-09-08 | 2016-09-26 | EOX | 02 | Y | CAPECITABINE + RT | 100265545 |
| 20213649 | 20129423 | 1.8 | 68.2 | Palliative (P) | 2017-03-04 | 2017-04-02 | Sorafenib | 02 | N | SORAFENIB | 101471853 |
| 20213650 | 20129424 | 1.67 | 54.8 | null | 2019-05-27 | 2019-05-29 | CAPECITABINE + RT | 02 | Y | CAPECITABINE + RT | 100907422 |
| 20213652 | 20129425 | 1.71 | 78 | Neo-adjuvant (N) | 2019-02-01 | 2019-03-23 | EOX | 01 | Y | CETUXIMAB + IRINOTECAN + MDG | 101417359 |
| 20213653 | 20129426 | 1.81 | 102.4 | Palliative (P) | 2019-01-30 | 2019-02-14 | EOX | 2 | N | TRIAL | 101575028 |
| 20213654 | 20129427 | 1.72 | 65.4 | Curative (C) | 2016-08-05 | 2016-08-16 | Sorafenib | 02 | Y | SORAFENIB | 100412663 |
| 20213655 | 20129428 | 1.5 | 92.2 | null | 2018-01-05 | 2018-01-30 | Cetuximab + Oxaliplatin + MdG Maint | N | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100522680 |
| 20213656 | 20129429 | 1.69 | 78 | Adjuvant (A) | 2015-08-10 | 2018-01-31 | EOX | 02 | N | EOX | 100301757 |
| 20213657 | 20129430 | 2 | 80.1 | Palliative (P) | 2016-08-30 | 2017-01-26 | Capecitabine 35days + RT | 02 | N | CAPECITABINE + RT | 100605888 |
| 20213658 | 20129431 | 1.61 | 63.5 | Curative (C) | 2017-04-12 | 2017-04-21 | EOX | 02 | N | CAPECITABINE + RT | 100418921 |
| 20213659 | 20129432 | 1.7 | 95.4 | Neo-adjuvant (N) | 2016-03-26 | 2016-03-30 | EOX | 02 | N | EOX | 100031840 |
| 20213660 | 20129433 | 1.81 | 93.3 | Palliative (P) | 2018-09-09 | 2018-09-20 | EOX | 02 | N | EOX | 100018479 |
| 20213661 | 20129434 | 1.93 | 46.8 | Curative (C) | 2020-06-20 | 2020-07-14 | Oxaliplatin + Raltitrexed | 02 | Y | OXALIPLATIN + RALTITREXED | 101863136 |
| 20213662 | 20129435 | 1.74 | 108.8 | Palliative (P) | 2018-04-25 | 2018-04-30 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101409671 |
| 20213666 | 20129436 | 1.76 | 90 | Palliative (P) | 2018-10-04 | 2018-10-15 | Trial Unspecified | 2 | N | TRIAL | 100721515 |
| 20213668 | 20129437 | 1.7 | 48.6 | Palliative (P) | 2018-01-10 | 2018-01-31 | EOX | 02 | N | EOX | 101486632 |
| 20213671 | 20129438 | 1.69 | 102.9 | Palliative (P) | 2021-04-05 | 2021-04-26 | EOX | N | N | EOX | 101842162 |
| 20213672 | 20129439 | 1.71 | 78.4 | Palliative (P) | 2018-01-17 | 2018-01-17 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 101766472 |
| 20213673 | 20129440 | 1.7 | 56.8 | null | 2016-04-07 | 2016-06-09 | EOX | 01 | null | CETUXIMAB + IRINOTECAN + MDG | 101288605 |
| 20213677 | 20129441 | 1.61 | 89.3 | Adjuvant (A) | 2018-01-22 | 2018-05-28 | EOX | 02 | N | EOX | 100926028 |
| 20213678 | 20129442 | 1.62 | null | null | 2017-07-13 | 2018-09-02 | EOX | 99 | null | CETUXIMAB + IRINOTECAN + MDG | 101355928 |
| 20213679 | 20129443 | 1.76 | 70.5 | Curative (C) | 2016-11-30 | 2018-08-30 | Sorafenib | 02 | Y | SORAFENIB | 100847309 |
| 20213681 | 20129444 | 1.46 | 62 | 03 | 2019-08-08 | 2019-08-18 | Capecitabine 35days + RT | 02 | null | EOX | 101060283 |
| 20213684 | 20129445 | 1.66 | 67.5 | Palliative (P) | 2018-12-08 | 2018-12-11 | Sorafenib | 2 | N | SORAFENIB | 100524378 |
| 20213685 | 20129446 | 1.74 | 86.45 | Disease modification (D) | 2021-01-07 | 2021-01-28 | Sorafenib | 02 | Y | SORAFENIB | 101816863 |
| 20213687 | 20129447 | 1.67 | 69.3 | Palliative (P) | 2019-03-21 | 2019-03-26 | EOX | N | N | TRIAL | 101609288 |
| 20213688 | 20129448 | 1.74 | 41.7 | Curative (C) | 2019-01-12 | 2019-02-24 | Trial Unspecified | 02 | N | TRIAL | 101814265 |
| 20213689 | 20129449 | 1.6 | 100 | Neo-adjuvant (N) | 2016-04-30 | 2016-05-07 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101601514 |
| 20213691 | 20129451 | 1.8 | 62.7 | Adjuvant (A) | 2018-08-18 | 2018-10-18 | Oxaliplatin + Raltitrexed | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100447855 |
| 20213692 | 20129452 | 1.76 | 93.95 | Palliative (P) | 2016-04-19 | 2016-11-07 | EOX | 02 | null | CETUXIMAB + IRINOTECAN + MDG | 101375403 |
| 20213693 | 20129453 | 1.72 | 78 | Neo-adjuvant (N) | 2017-05-28 | 2017-06-08 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101440098 |
| 20213697 | 20129454 | null | 62.9 | Palliative (P) | 2018-09-07 | 2018-10-06 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100147694 |
| 20213699 | 20129455 | 1.7 | 68 | Palliative (P) | 2019-09-15 | 2019-10-02 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101061127 |
| 20213700 | 20129456 | 1.74 | 83 | Palliative (P) | 2017-07-20 | 2017-07-21 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 100951369 |
| 20213704 | 20129457 | 1.7 | 69.95 | null | 2019-02-14 | 2019-02-15 | EOX | 02 | null | OXALIPLATIN + RALTITREXED | 101864931 |
| 20213707 | 20129458 | 1.81 | 0 | Palliative (P) | 2017-01-27 | 2017-12-31 | Capecitabine 35days + RT | 02 | N | CAPECITABINE + RT | 101131647 |
| 20213708 | 20129459 | 1.78 | 71.3 | Palliative (P) | 2016-04-24 | 2016-05-06 | Trial Unspecified | 02 | Y | TRIAL | 100603001 |
| 20213709 | 20129460 | 1.7 | 60 | null | 2017-07-03 | 2017-10-03 | EOX | 2 | null | SORAFENIB | 100297665 |
| 20213710 | 20129461 | 1.81 | 60 | Neo-adjuvant (N) | 2020-08-03 | 2020-08-15 | Sorafenib | 02 | N | SORAFENIB | 101644828 |
| 20213711 | 20129462 | 1.55 | 72.4 | null | 2018-12-27 | 2019-04-18 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 100086572 |
| 20213712 | 20129463 | 1.59 | 61 | Palliative (P) | 2018-01-03 | 2018-07-21 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 101365598 |
| 20213713 | 20129464 | 1.92 | 74.9 | null | 2016-08-16 | 2016-08-30 | EOX | 02 | N | EOX | 101393570 |
| 20213715 | 20129465 | 1.71 | 112 | Palliative (P) | 2017-06-13 | 2017-10-17 | Capecitabine 35days + RT | 02 | N | CAPECITABINE + RT | 101729003 |
| 20213717 | 20129466 | 1.75 | 79.4 | 03 | 2018-06-16 | 2020-03-09 | EOX | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101017893 |
| 20213719 | 20129467 | 1.7 | 61.6 | Palliative (P) | 2017-05-02 | 2017-05-03 | EOX | 01 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100856487 |
| 20213722 | 20129468 | 1.66 | 77 | Palliative (P) | 2018-07-07 | 2018-07-09 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100382193 |
| 20213723 | 20129469 | 1.49 | 43.5 | Adjuvant (A) | 2016-07-27 | 2016-07-27 | EOX | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100344167 |
| 20213725 | 20129470 | 1.62 | 93 | Neo-adjuvant (N) | 2017-12-09 | 2017-12-21 | Sorafenib | 02 | Y | SORAFENIB | 100768604 |